Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Oxaliplatin followed by Chemoradiotherapy in Pancreatic Cancer
NCT02984501Phase 2Completed
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Mar 2013
- Primary completion
- Aug 2016
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of gemcitabine, oxaliplatin in pancreatic cancer (PC), sponsored by Università Campus Bio-Medico di Roma. Started Mar 2013; status: completed.
02
Drugs
gemcitabineoxaliplatin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02984501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02984501.